Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Linnaeus Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Linnaeus Therapeutics

Linnaeus Therapeutics

Linnaeus Therapeutics, Inc.: A clinical-stage biopharma firm developing novel oncology therapeutics.

HQ
Haddonfield, NJ, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Linnaeus Therapeutics, Inc. is a privately-held clinical-stage biopharmaceutical company founded with the mission to develop and commercialize novel small molecule oncology therapeutics targeting G protein-coupled receptors. The company focuses on creating innovative treatments for various cancers, with a particular emphasis on metastatic cutaneous melanoma. Their flagship product, LNS8801, is currently undergoing clinical trials and has been granted Orphan Drug Designation for its potential in treating this aggressive form of skin cancer.

Notable figures associated with Linnaeus Therapeutics include experienced leaders in the biopharmaceutical industry, though specific names are not provided. The company has achieved significant milestones, such as receiving Orphan Drug Designation for LNS8801, which underscores its potential impact on cancer treatment. Linnaeus Therapeutics aims to make a substantial contribution to oncology by offering new hope through targeted therapies, potentially improving outcomes for patients with difficult-to-treat cancers.

Linnaeus Therapeutics - Similar Companies

Lassen Therapeutics logo

Lassen Therapeutics

Grannus Therapeutics logo

Grannus Therapeutics

Seneca Therapeutics logo

Seneca Therapeutics

Cullinan Oncology logo

Cullinan Oncology

Geneos Therapeutics logo

Geneos Therapeutics

geneostx.com

Traws Pharma logo

Traws Pharma

858 Therapeutics logo

858 Therapeutics

8five8tx.com

Stellanova Therapeutics logo

Stellanova Therapeutics

stellanovatx.com

Palm Therapeutics logo

Palm Therapeutics

Starton Therapeutics logo

Starton Therapeutics

Synnovation Therapeutics logo

Synnovation Therapeutics

synnovationtx.com

Kestrel Therapeutics logo

Kestrel Therapeutics

PineTree Therapeutics logo

PineTree Therapeutics

pinetreetx.com

G1 Therapeutics logo

G1 Therapeutics

g1therapeutics.com

Zenopharm logo

Zenopharm

Linnaeus Therapeutics - Quick Facts

Who are Linnaeus Therapeutics' competitors?

Companies similar to Linnaeus Therapeutics include Lassen Therapeutics, Grannus Therapeutics, Seneca Therapeutics and Cullinan Oncology.

When was Linnaeus Therapeutics founded?

Linnaeus Therapeutics was founded in 2016.

Where is Linnaeus Therapeutics' headquarters located?

Linnaeus Therapeutics' headquarters is located in Haddonfield, NJ, US.

When was Linnaeus Therapeutics' last funding round?

Linnaeus Therapeutics' most recent funding round was for $3.1M (USD) in January 2023.

How much has Linnaeus Therapeutics raised to-date?

As of Jan 26, 2023, Linnaeus Therapeutics has raised a total of $23.8M (USD).

How many employees does Linnaeus Therapeutics have?

Linnaeus Therapeutics has 8 employees as of Feb 5, 2024.

Linnaeus Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Oncology Therapeutics
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified